Zobrazeno 1 - 10
of 117
pro vyhledávání: '"G. C. Manzoni"'
Autor:
Nicola Vanacore, Licia Grazzi, D. D’Amico, S. Cevoli, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Paola Torelli, Francesco Infarinato, Piero Barbanti, Pietro Cortelli, G. C. Manzoni
Publikováno v:
Publons
To optimize chronic migraine (CM) ascertainment and phenotype definition, provide adequate clinical management and health care procedures, and rationalize economic resources allocation, we performed an exploratory multicenter pilot study aimed at est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2fd29fbf4346fdfef406f36d95ea6f9
http://hdl.handle.net/11585/642756
http://hdl.handle.net/11585/642756
Autor:
G. C. Manzoni, Paola Torelli
Publikováno v:
Neurological Sciences. 36:51-55
The International Classification of Headache Disorders, 3rd edition (beta version) has significantly improved the categorization of chronic headaches. From a clinical standpoint, however, it still has a few limitations, both general and specific. Amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b75f1f05b0e425bfff8f666a4395fe6
https://doi.org/10.1007/s10072-015-2142-0
https://doi.org/10.1007/s10072-015-2142-0
Autor:
G C, Manzoni
Publikováno v:
Italian journal of neurological sciences. 16(9)
Following a short analysis of leading principles of the classification and diagnostic criteria of headaches of the International Headache Society (IHS) and a brief description of its nosography of primary headaches, some still debated issues are disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b36f70b745f23cf597ede28df0eb796b
https://pubmed.ncbi.nlm.nih.gov/27315253
https://pubmed.ncbi.nlm.nih.gov/27315253
Autor:
Paola Torelli, G. C. Manzoni
Publikováno v:
Neurological Sciences. 33:13-16
In the field of primary headaches, we have a very useful classification tool for the clinical characterization of individual attacks, but we lack a classification tool for the characterization of primary headache patients. Just because the reasons fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33310319f4143ef4811f17b9e7693f69
https://doi.org/10.1007/s10072-012-1035-8
https://doi.org/10.1007/s10072-012-1035-8
Autor:
G. C. Manzoni, Paola Torelli
Publikováno v:
Neurological Sciences. 32:45-49
The analysis of case series of new daily persistent headache (NDPH) reported so far in the literature and the clinical evaluation of affected patients seen at headache clinics suggest that the current International Classification of Headache Disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dbb3cd638fb122859b37f0106803645
https://doi.org/10.1007/s10072-011-0534-3
https://doi.org/10.1007/s10072-011-0534-3
Autor:
Paola Torelli, G. C. Manzoni
Publikováno v:
Neurological Sciences. 30:81-84
The question in the title of this article arises from ambiguities in the diagnostic criteria for chronic migraine (CM) included in the 2004 International Classification of Headache Disorders, 2nd Edition (ICHD-II), and in the 2006 revision. More broa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdff2fa2506644ad885633bb3c8bb7cd
https://doi.org/10.1007/s10072-009-0078-y
https://doi.org/10.1007/s10072-009-0078-y
Autor:
Peter J. Goadsby, Andrew J. Dowson, Julio Pascual, Carl Dahlöf, Markus Färkkilä, Luís Cunha, G. C. Manzoni, Valentín Mateos, Hans-Christoph Diener, Hélène Massiou, I. Raets
Publikováno v:
Acta Neurologica Scandinavica. 115:34-40
Objective: To compare almotriptan and zolmitriptan in the treatment of acute migraine. Methods: This multicentre, double-blind trial randomized adult migraineurs to almotriptan 12.5 mg (n = 532) or zolmitriptan 2.5 mg (n = 530) for the treatment of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5ee1d0db243cc10eff6d662967334
https://doi.org/10.1111/j.1600-0404.2006.00739.x
https://doi.org/10.1111/j.1600-0404.2006.00739.x
Publikováno v:
Headache: The Journal of Head and Face Pain. 45:644-652
Background.—In the absence of biological markers, the diagnosis of cluster headache (CH) rests on clinical evidence as reported through ad-hoc interviews. Objective.—The aim of this study was to validate a 16-item self-administered questionnaire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0b6cfd4dd3debd798b5f4a9f32a9f1
https://doi.org/10.1111/j.1526-4610.2005.05131.x
https://doi.org/10.1111/j.1526-4610.2005.05131.x
Autor:
G. C. Manzoni, Paola Torelli
Publikováno v:
Neurological Sciences. 25:s119-s122
The clinical management of cluster headache (CH) attacks requires a symptomatic treatment that is rapidly effective in resolving or significantly reducing symptoms. First-choice drugs for the symptomatic treatment of CH are subcutaneous sumatriptan a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e41bff1c66197db9b484ce6b9e7741
https://doi.org/10.1007/s10072-004-0267-7
https://doi.org/10.1007/s10072-004-0267-7